Literature DB >> 20039103

The significance of genetic polymorphisms of factor V Leiden and prothrombin in the preeclamptic Polish women.

Agnieszka Seremak-Mrozikiewicz1, Krzysztof Drews, Ewa Wender-Ozegowska, Przemyslaw M Mrozikiewicz.   

Abstract

Many studies established that gestational hypertension (GH) and preeclampsia (PE) are multifactorial diseases and disturbances in coagulation cascade have etiological significance. Inherited thrombophilias, like polymorphism of factor V (FV) Leiden and prothrombin (PTM) are considered to be involved in the PE development. The aim of this study was to determine the association between FV Leiden and G20210A of PTM gene polymorphism and GH/PE appearance. The study comprised 235 women: GH (n = 126, mean age 27.5 +/- 6.0 years), mild PE (n = 41, mean age 28.3 +/- 5.7 years), and severe PE (n = 68, mean age 28.5 +/- 5.7 years). The control group consisted of 400 healthy pregnant women (mean age 27.5 +/- 4.7 years). All women included in the study were white Caucasian of Polish origin, and were singleton pregnancies. The G1691A polymorphism of FV and G20210A polymorphism of PTM were detected using polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP) assays. For PTM G20210A polymorphism overrepresentation of heterozygous GA genotype (7.4 vs. 1.2%, P = 0.02) and of A allele (3.7 vs. 0.6%, P = 0.02) in the group of severe PE have been found. For FV G1691A polymorphism the overrepresentation of genotypes containing at least one mutated allele A (GA and AA) in the group of women with mild (9.7 vs. 3.5%, ns) and severe PE (8.8 vs. 3.5%, ns) was observed. Our results suggest the significant influence of G20210A prothrombin polymorphism and possible influence of G1691A factor V polymorphism in the development of severe preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20039103     DOI: 10.1007/s11239-009-0432-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  33 in total

Review 1.  Advances in understanding pathogenic mechanisms of thrombophilic disorders.

Authors:  Björn Dahlbäck
Journal:  Blood       Date:  2008-07-01       Impact factor: 22.113

2.  Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.

Authors:  Touhami Mahjoub; Nabil Mtiraoui; Hala Tamim; Sondes Hizem; Ramzi R Finan; Brahim Nsiri; Wassim Y Almawi
Journal:  Am J Hematol       Date:  2005-09       Impact factor: 10.047

Review 3.  Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene.

Authors:  B Dahlbäck
Journal:  Haemostasis       Date:  1994 Mar-Apr

4.  Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia.

Authors:  Angela V D'Elia; Lorenza Driul; Roberta Giacomello; Roberta Colaone; Dora Fabbro; Cristina Di Leonardo; Pasquale Florio; Felice Petraglia; Diego Marchesoni; Giuseppe Damante
Journal:  Gynecol Obstet Invest       Date:  2002       Impact factor: 2.031

5.  Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome.

Authors:  T Agorastos; A Karavida; A Lambropoulos; T Constantinidis; S Tzitzimikas; S Chrisafi; H Saravelos; D Vavilis; A Kotsis; J Bontis
Journal:  J Matern Fetal Neonatal Med       Date:  2002-10

6.  Thrombophilic mutations are a main risk factor for placental abruption.

Authors:  Fabio Facchinetti; Luca Marozio; Elvira Grandone; Cristina Pizzi; Annibale Volpe; Chiara Benedetto
Journal:  Haematologica       Date:  2003-07       Impact factor: 9.941

Review 7.  Thrombophilias and recurrent miscarriage.

Authors:  Amy M Adelberg; Jeffrey A Kuller
Journal:  Obstet Gynecol Surv       Date:  2002-10       Impact factor: 2.347

Review 8.  Factor V Leiden mutation in pregnancy.

Authors:  Susan Murphy Cohen
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2004 May-Jun

9.  Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: a pilot study.

Authors:  Clemens B Tempfer; Stefan Jirecek; Eva-Katrin Riener; Harald Zeisler; Dominik Denschlag; Lukas Hefler; Peter W Husslein
Journal:  J Soc Gynecol Investig       Date:  2004-05

Review 10.  Thrombophilia and pregnancy complications: cause or association?

Authors:  S Middeldorp
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

View more
  7 in total

1.  Prevalence of 1691G>A FV mutation in Poland compared with that in other Central, Eastern and South-Eastern European countries.

Authors:  Grażyna Adler; Jeremy S C Clark; Beata Loniewska; Ewa Czerska; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

2.  Thrombophilic mutations and susceptibility to preeclampsia in Western Iran.

Authors:  Shohreh Malek-Khosravi; Zohreh Rahimi; Ziba Rahimi; Faranak Jalilvand; Abbas Parsian
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

Review 3.  Pathogenesis of preeclampsia: the genetic component.

Authors:  Francisco J Valenzuela; Alejandra Pérez-Sepúlveda; María J Torres; Paula Correa; Gabriela M Repetto; Sebastián E Illanes
Journal:  J Pregnancy       Date:  2011-12-01

4.  Association of Deficiency of Coagulation Factors (Prs, Prc, ATIII) and FVL Positivity with Preeclampsia and/or Eclampsia in Pregnant Women.

Authors:  Maryam Al-E-Rasul Dehkordi; Akbar Soleimani; Ali Haji-Gholami; Abdolrahim Kazemi Vardanjani; Saeid Al-E-Rasul Dehkordi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014-10-01

5.  The role of FV 1691G>A, FII 20210G>A mutations and MTHFR 677C>T; 1298A>C and 103G>T FXIII gene polymorphisms in pathogenesis of intraventricular hemorrhage in infants born before 32 weeks of gestation.

Authors:  Dawid Szpecht; Janusz Gadzinowski; Agnieszka Seremak-Mrozikiewicz; Grażyna Kurzawińska; Krzysztof Drews; Marta Szymankiewicz
Journal:  Childs Nerv Syst       Date:  2017-06-03       Impact factor: 1.475

6.  Entropy-based selection for maternal-fetal genotype incompatibility with application to preterm prelabor rupture of membranes.

Authors:  Shaoyu Li; Yuehua Cui; Roberto Romero
Journal:  BMC Genet       Date:  2014-06-10       Impact factor: 2.797

7.  Association between thrombophilia gene polymorphisms and preeclampsia: a meta-analysis.

Authors:  Xi Wang; Tingting Bai; Shengnan Liu; Hong Pan; Binbin Wang
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.